News Release

Benign uterine tumor resembling cancer highlights diagnostic challenges

“This case highlights that lipoleiomyomas can present many years after attaining menopause.”

Peer-Reviewed Publication

Impact Journals LLC

Navigating diagnostic complexity: A case report on uterine lipoleiomyoma, unveiling its benign nature amidst characteristics resembling liposarcoma

image: 

Figure 2: (A, B) Cut-surface of hysterectomy specimen displaying anterior uterine wall fibroid with no yellowish areas; (C, D) Cut-surface of subserosal fibroid showing yellowish area in the centre (blue arrow); (E, F) Microphotographs of intramural and subserosal fibroid, respectively, showing aggregates of mature adipocytes intermingled with bundles of smooth muscle cells (100×, Haematoxylin and Eosin); (G, H) Higher power showing intra-tumoral eosinophils (few circled in red) and mast cells (few circled in blue) (400×, Haematoxylin and Eosin); (I) A focus showing a vessel with a surrounding collar of smooth muscle cells and adipocytes (100×, Haematoxylin and Eosin).

view more 

Credit: Copyright: © 2025 Palo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

“This case highlights that lipoleiomyomas can present many years after attaining menopause.”

BUFFALO, NY — July 18, 2025 — A new case report was published in Volume 12 of Oncoscience on July 2, 2025, titled “Navigating diagnostic complexity: A case report on uterine lipoleiomyoma, unveiling its benign nature amidst characteristics resembling liposarcoma.”

In this report, Seetu Palo, first corresponding author Mishu Mangla and colleagues from the All India Institute of Medical Sciences describe a rare case where a benign uterine tumor closely resembles a malignant tumor in an elderly patient. Their findings emphasize the importance of careful diagnosis in post-menopausal women with fibroid-like symptoms to avoid unnecessary aggressive treatments.

Lipoleiomyomas are uncommon benign tumors in the uterus made up of smooth muscle and fat cells. One such tumor was identified in a 75-year-old woman, 25 years post-menopause, who presented with persistent lower abdominal pain. Imaging revealed two fibroid-like masses, and surgery confirmed features of lipoleiomyoma. Detailed microscopic analysis established the benign nature of the tumors despite their initial resemblance to malignant liposarcoma.

Accounting for only 0.03–2.1% of all uterine fibroids, these rare tumors usually appear in post-menopausal women. The patient in this report also had diabetes and hypertension, supporting the theory that metabolic changes after menopause may contribute to their development.

The authors also point to the fact that light microscopy remains the gold standard for distinguishing lipoleiomyomas from malignant counterparts. Imaging techniques such as MRI may not detect fat components in smaller lesions, which can complicate diagnosis and increase the risk of misinterpretation.

By documenting this unusual case, the team aims to raise awareness among healthcare professionals about this rare condition. Greater vigilance in histopathological evaluation can prevent misdiagnosis and reduce the likelihood of unnecessary interventions. This case report also adds knowledge to the limited literature on lipoleiomyomas and recommends a careful assessment when such tumors are suspected in elderly patients.

Continue reading: DOI: https://doi.org/10.18632/oncoscience.621

Correspondence to: Mishu Mangla – mishusingla83@gmail.com

Keywords: cancer, lipoleiomyoma, variant, leiomyoma, post-menopausal, case report

Click here to sign up for free Altmetric alerts about this article.

About Oncoscience

Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication cost. It is free for the readers and the authors.

Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:

Click here to subscribe to Oncoscience publication updates.

For media inquiries, please contact media@impactjournals.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.